Prolonged rapamycin treatment inhibits mTORC2 and Akt/PKB assembly - Review of the evidence
Evidence from cell and animal studies shows prolonged rapamycin can inhibit mTORC2 assembly and Akt signaling. Clinical relevance remains uncertain.
Authors
- Deborah Iodice (ORCID: https://orcid.org/0009-0004-6095-5471)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24366638
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00